Skip to main content

Journals in Medical and veterinary entomology

Current Research in Parasitology and Vector-Borne Diseases

  • ISSN: 2667-114X
  • 5 Year impact factor: 1.7
  • Impact factor: 1.7
Current Research in Parasitology & Vector-Borne Diseases (CRPVBD) is a new primary research, gold open access journal from Elsevier. CRPVBD publishes Original Research articles, Short Communications, Letters, Opinion and Methodology articles as well as Reviews, Rapid Reviews and Graphical Reviews, that cover all aspects of human and animal parasitology and vector biology and vector-borne pathogens.Current Research in Parasitology & Vector-Borne Diseases is a peer-reviewed gold open access (OA) journal and upon acceptance all articles are permanently and freely available. It is part of the Current Opinion and Research (CO+RE) suite of journals . All CO+RE journals leverage the Current Opinion legacy of editorial excellence, high-impact, and global reach, to ensure they are a widely read resource.Current Research in Parasitology & Vector-Borne Diseases main research areas covered include (but are not restricted to):Diversity, distribution, ecology, life cycles and transmission biology of parasites and arthropod vectors.Identification, taxonomy, systematics and molecular phylogenetics of parasites and arthropod vectors.Surveillance of indigenous and invasive arthropod vectors of public and veterinary health relevance: distribution, abundance and bionomics. Assessment of vector-pathogen relationships and the risk of pathogen transmission and associated disease.Mathematical modelling of parasite and vector populations, parasitic infections, host-parasite and vector-pathogen interactions, and epidemiology of zoonotic and emerging/re-emerging infectious diseases.Impact of environmental change on the transmission dynamics of parasites and the biology, ecology and distribution of intermediate hosts and vectors. Emergence, re(emergence) and globalisation of vectors, pathogens and hosts and One Health.Parasitic and vector-borne diseases of humans, wildlife and domestic, farm and companion animals including studies on immunology, immunopathology, diagnosis and control.Neglected tropical diseases (NTDs): diagnosis, monitoring, control and eradication/elimination. Model-based analyses addressing the transmission dynamics and control of Chagas disease, visceral leishmaniasis, human African trypanosomiasis, soil-transmitted helminths, schistosomiasis, lymphatic filariasis, onchocerciasis and trachoma.Molecular aspects of parasite and vector diversity and evolution including molecular epidemiology and population genetics mechanisms of anti-parasite drug resistance and insecticide resistance in arthropod vectors.Use of genomics, proteomics and bioinformatics technologies to study host-parasite/pathogen and parasite-host-microbiota interactions, and pathogen-microbiome interaction in vectors.Economic impact assessments of parasitic infections or vector-borne diseases.Outbreak investigations and impact assessments.Topics which may be considered for the journal only if the following requirements are met:Studies assessing prevalence rates of parasites and pathogens in arthropod vectors (ticks, mosquitoes, sand flies) that are not restricted to local or small regional scales and address gaps in large-scale temporal and/or spatial patterns of host-parasite and arthropod-pathogen systems.Major reviews of the systematics and taxonomy of parasites and arthropod vectors that provide a novel background in the field.Assessment of novel chemicals (attractants, adulticides of larvicides) if at an advanced stage with extensive laboratory data and chemical analysis to characterize active ingredients and field data on efficacy and biosafety.Clinical trial studies if these include mechanistic insight into intervention efficacy from parasitology and/or vector data.Current Research in Parasitology & Vector-Borne Diseases builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health.Expertise - Editors and Editorial Board bring depth and breadth of expertise and experience to the journal.Speed - Submission and peer review is fast, and publication of final manuscripts is instantaneous.Discoverability - Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast global audience.Ethics in Publishing: General StatementThe Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. For more information, please refer to: https://www.elsevier.com/conflictsofinterest
Current Research in Parasitology and Vector-Borne Diseases

International Journal for Parasitology: Drugs and Drug Resistance

  • ISSN: 2211-3207
  • 5 Year impact factor: 3.7
  • Impact factor: 4.1
Sponsored by the Australian Society for ParasitologyThe International Journal for Parasitology – Drugs and Drug Resistance is one of a series of specialist, open access journals launched by the International Journal for Parasitology . It publishes the results of original research, as well as review articles, in the area of anti-parasite drug identification, development and evaluation, and parasite drug resistance. The journal also covers research into natural products as anti-parasitic agents, and bioactive parasite products. Studies can be aimed at unicellular or multicellular parasites of human or veterinary importance.A list showing the types of articles that are considered is included below. Original research includes the development of novel and innovative concepts and ideas, as well as experimental and observational science that raises new hypotheses. Because of its breadth of organism coverage, all contributions should include relevant information about the parasite of interest in order to be comprehensible to non-experts in the particular subject of the articles. The principal forms of publication are full-length articles which contain substantial results from a major program of research, or reviews on topical issues and strategically important subjects. The journal also accepts brief reports that have similar subject scope as the full-length article, but do not merit a full-length publication.In addition, the journal provides a medium for highlighting selected articles reporting highly significant original findings, as Editor's Choice Manuscripts. The journal encourages critical comment and debate on matters of current controversy in the area of parasite drug resistance and anti-parasite drugs via "Current Opinions".This title is fully open access and therefore funded not through library subscription payments but through author fees. If you would like your article to be published open access, but you genuinely cannot afford these fees, then individual waiver requests are considered on a case-by-case basis and may be granted in cases of genuine need. Priority for this waiver programme will be given to applications by authors from countries eligible for the Research4Life programme (see http://www.research4life.org/institutions.html).Types of articles considered:Compound library screening for inhibitors against enzymes or whole parasitesDrug target validation (chemical and/or genetic)Drug target identification (must include some inhibitor studies rather than characterisation of an enzyme, for example)Drug structure-activity relationship studiesMechanisms of drug action and resistanceReports of the development of drug resistance both in the field and laboratoryStudies on drug toxicity to the host (either on single host cells or whole organism)Reports on toxicity in the fieldComputational approaches to drug discovery or drug-target identificationDevelopment of assays directed at screening for inhibitorsDrug combination studiesNatural products as anti-parasitic agentsBioactive products produced by parasitesUse of live parasites as immunomodulatory agentsEpidemiological aspects of the emergence and spread of parasite drug resistanceHuman clinical trialsThe other specialist title in the series is International Journal for Parasitology: Parasites and Wildlife .
International Journal for Parasitology: Drugs and Drug Resistance

International Journal for Parasitology: Parasites and Wildlife

  • ISSN: 2213-2244
  • 5 Year impact factor: 2.1
  • Impact factor: 2
Sponsored by the Australian Society for ParasitologyThe International Journal for Parasitology: Parasites and Wildlife (IJP-PAW) publishes the results of original research on parasites of all wildlife, invertebrate and vertebrate. This includes free-ranging,wild populations, semi-domesticated species (e.g. reindeer) and farmed populations of recently domesticated or wild-captured species (e.g. cultured fishes). Submissions describing studies on captive wildlife can be considered if they include relevant ecological, clinical, or epidemiological aspects. Articles on all aspects of wildlife parasitology are welcomed including taxonomy, evolutionary biology, biodiversity and distribution, ecology and epidemiology, population biology and host-parasite relationships. The impact of parasites on the health and conservation of wildlife is seen as an important area covered by the journal especially the potential role of environmental factors, for example, climate. Also important to the journal is One Health and the nature of interactions between wildlife, people and domestic animals, including disease emergence and zoonoses.The principal form of publication is the full-length article which contains substantial, original research. The journal also accepts brief reports that have similar subject scope as the full-length article, but do not merit a full-length publication. In addition, the journal commissions articles with emphasis on shorter, focused reviews of topical and emerging issues as well as strategically important subjects. The journal encourages critical comment and debate on matters of current controversy in the area of parasites and wildlife via "Current Opinions".This title is fully open access and therefore funded not through library subscription payments but through author fees. If you would like your article to be published open access, but you genuinely cannot afford these fees, then individual waiver requests are considered on a case-by-case basis and may be granted in cases of genuine need. Priority for this waiver programme will be given to applications by authors from countries eligible for the Research4Life programme (see http://www.research4life.org/institutions.html).The other specialist title in the series is International Journal for Parasitology: Drugs and Drug Resistance .
International Journal for Parasitology: Parasites and Wildlife

Ticks and Tick-borne Diseases

  • ISSN: 1877-959X
  • 5 Year impact factor: 3.1
  • Impact factor: 3.1
Ticks and Tick-borne Diseases is an international, peer-reviewed scientific journal. It publishes original research papers, short communications, state-of-the-art mini-reviews, letters to the editor, clinical-case studies, announcements of pertinent international meetings, opinion papers and editorials. The journal covers a broad spectrum and brings together various disciplines, for example, zoology, microbiology, molecular biology, genetics, mathematical modelling, veterinary and human medicine. Multidisciplinary approaches and the use of conventional and novel methods/methodologies (in the field and in the laboratory) are crucial for deeper understanding of the natural processes and human behaviour/activities that result in human or animal diseases and in economic effects of ticks and tick-borne pathogens. Such understanding is essential for management of tick populations and tick-borne diseases in an effective and environmentally acceptable manner. The journal covers the following topics:Ticks: biosystematics/taxonomy, morphology, evolution, ecology, physiology/biochemistry, behaviour, molecular biology, genomics/proteomics, and controlEcology/ecoepidemiology of tick-borne diseases: vector ticks and reservoir hosts, the mechanisms and processes determining their abundance and distribution, the occurrence and prevalence of pathogens in tick and tick-host populations, tick-host-pathogen interactions at the ecological level and their dependence upon environmental factors, natural focality, and risk assessments of exposure to ticks and the occurrence of tick-borne diseasesTick-borne pathogens: viruses, bacteria, and parasites, their biology in ticks and vertebrates, pathogen-tick and pathogen-host interactions on the molecular and cellular levels, transmission, coinfection, genomics/proteomics, and biosystematics/taxonomyTick-borne diseases in domestic animals and wildlife: epidemiology, diagnosis, immunology, treatment, vaccination, control/management, and economicsTick-borne human diseases: epidemiology, diagnosis, immunology, treatment, vaccination, socioeconomics, and public healthIn addition, methodological papers on all these areas will be published as well as timely reviews on vectors and vector-borne diseases in which tick biology or tick-borne diseases are addressed.
Ticks and Tick-borne Diseases